CryoLife Net Income Applicable To Common Shares from 2010 to 2026
| CYL Stock | EUR 29.75 1.90 6.00% |
Net Loss | First Reported 2016-12-31 | Previous Quarter -3.4 M | Current Value -3.4 M | Quarterly Volatility 5.6 M |
Check CryoLife financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CryoLife's main balance sheet or income statement drivers, such as Interest Expense of 41.4 M, Selling General Administrative of 148.1 M or Total Revenue of 280.8 M, as well as many indicators such as . CryoLife financial statements analysis is a perfect complement when working with CryoLife Valuation or Volatility modules.
CryoLife | Net Income Applicable To Common Shares |
The Net Income Applicable To Common Shares trend for CryoLife offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether CryoLife is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest CryoLife's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of CryoLife over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. CryoLife's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CryoLife's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
CryoLife Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (4,074,939) | |
| Geometric Mean | 8,515,330 | |
| Coefficient Of Variation | (292.48) | |
| Mean Deviation | 11,009,223 | |
| Median | 1,708,000 | |
| Standard Deviation | 11,918,241 | |
| Sample Variance | 142T | |
| Range | 29.7M | |
| R-Value | (0.90) | |
| Mean Square Error | 29.4T | |
| R-Squared | 0.81 | |
| Slope | (2,118,442) | |
| Total Sum of Squares | 2272.7T |
CryoLife Net Income Applicable To Common Shares History
About CryoLife Financial Statements
CryoLife stakeholders use historical fundamental indicators, such as CryoLife's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although CryoLife investors may analyze each financial statement separately, they are all interrelated. For example, changes in CryoLife's assets and liabilities are reflected in the revenues and expenses on CryoLife's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CryoLife. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -17.2 M | -16.3 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in CryoLife Stock
CryoLife financial ratios help investors to determine whether CryoLife Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CryoLife with respect to the benefits of owning CryoLife security.